<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 900px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             

             
             #config {
                 float: left;
                 width: 400px;
                 height: 600px;
             }
             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
        
            <div id="config"></div>
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "infection", "label": "infection", "shape": "dot", "size": 75, "title": "\u003cb\u003einfection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 20\u003cbr\u003e\n    Incoming: 7\u003cbr\u003e\n    Outgoing: 13\u003cbr\u003e\n    DOI: 10.1101/2025.09.27.25336412"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "JN.1/KP.2", "label": "JN.1/KP.2", "shape": "dot", "size": 18, "title": "\u003cb\u003eJN.1/KP.2\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682893"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "S-induced", "label": "S-induced", "shape": "dot", "size": 18, "title": "\u003cb\u003eS-induced\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682893"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "acute respiratory syndrome coronavirus 2", "label": "acute respiratory syndrome coronavirus 2", "shape": "dot", "size": 15, "title": "\u003cb\u003eacute respiratory syndrome coronavirus 2\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "RBD", "label": "RBD", "shape": "dot", "size": 21, "title": "\u003cb\u003eRBD\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "{Delta}3a7b-Nluc", "label": "{Delta}3a7b-Nluc", "shape": "dot", "size": 21, "title": "\u003cb\u003e{Delta}3a7b-Nluc\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "ARM", "label": "ARM", "shape": "dot", "size": 21, "title": "\u003cb\u003eARM\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "SARS-CoV-2 infection", "label": "SARS-CoV-2 infection", "shape": "dot", "size": 33, "title": "\u003cb\u003eSARS-CoV-2 infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 6\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 6\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "inflammation", "label": "inflammation", "shape": "dot", "size": 36, "title": "\u003cb\u003einflammation\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 7\u003cbr\u003e\n    Incoming: 5\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "viral infection", "label": "viral infection", "shape": "dot", "size": 18, "title": "\u003cb\u003eviral infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "AXiAEC", "label": "AXiAEC", "shape": "dot", "size": 24, "title": "\u003cb\u003eAXiAEC\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 3\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "ALI", "label": "ALI", "shape": "dot", "size": 24, "title": "\u003cb\u003eALI\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 3\u003cbr\u003e\n    Incoming: 3\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "SARS-CoV-2 infected", "label": "SARS-CoV-2 infected", "shape": "dot", "size": 15, "title": "\u003cb\u003eSARS-CoV-2 infected\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "LOC SARS-CoV-2 infection", "label": "LOC SARS-CoV-2 infection", "shape": "dot", "size": 21, "title": "\u003cb\u003eLOC SARS-CoV-2 infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "dibasic", "label": "dibasic", "shape": "dot", "size": 15, "title": "\u003cb\u003edibasic\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682669"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "OC43", "label": "OC43", "shape": "dot", "size": 15, "title": "\u003cb\u003eOC43\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682669"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "viral infections", "label": "viral infections", "shape": "dot", "size": 18, "title": "\u003cb\u003eviral infections\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682991"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "trametinib", "label": "trametinib", "shape": "dot", "size": 21, "title": "\u003cb\u003etrametinib\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "sorafenib", "label": "sorafenib", "shape": "dot", "size": 21, "title": "\u003cb\u003esorafenib\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "coronavirus infections", "label": "coronavirus infections", "shape": "dot", "size": 21, "title": "\u003cb\u003ecoronavirus infections\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "Tyrosine", "label": "Tyrosine", "shape": "dot", "size": 18, "title": "\u003cb\u003eTyrosine\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "pan-coronaviruses infection", "label": "pan-coronaviruses infection", "shape": "dot", "size": 18, "title": "\u003cb\u003epan-coronaviruses infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "HGS deficiency", "label": "HGS deficiency", "shape": "dot", "size": 15, "title": "\u003cb\u003eHGS deficiency\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "riboflavin tetrabutyrate", "label": "riboflavin tetrabutyrate", "shape": "dot", "size": 18, "title": "\u003cb\u003eriboflavin tetrabutyrate\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "RTB", "label": "RTB", "shape": "dot", "size": 18, "title": "\u003cb\u003eRTB\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "nucleic acid", "label": "nucleic acid", "shape": "dot", "size": 15, "title": "\u003cb\u003enucleic acid\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682549"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "weight loss", "label": "weight loss", "shape": "dot", "size": 21, "title": "\u003cb\u003eweight loss\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "nilotinib", "label": "nilotinib", "shape": "dot", "size": 21, "title": "\u003cb\u003enilotinib\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "tecovirimat", "label": "tecovirimat", "shape": "dot", "size": 21, "title": "\u003cb\u003etecovirimat\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "ST-246", "label": "ST-246", "shape": "dot", "size": 21, "title": "\u003cb\u003eST-246\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "urea", "label": "urea", "shape": "dot", "size": 18, "title": "\u003cb\u003eurea\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "hydrogen bond donor", "label": "hydrogen bond donor", "shape": "dot", "size": 18, "title": "\u003cb\u003ehydrogen bond donor\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "once-daily", "label": "once-daily", "shape": "dot", "size": 18, "title": "\u003cb\u003eonce-daily\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "uridine", "label": "uridine", "shape": "dot", "size": 18, "title": "\u003cb\u003euridine\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682008"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "ARCA", "label": "ARCA", "shape": "dot", "size": 18, "title": "\u003cb\u003eARCA\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682008"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "PASC", "label": "PASC", "shape": "dot", "size": 30, "title": "\u003cb\u003ePASC\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 5\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 5\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "infected with SARS-CoV-2 and viral", "label": "infected with SARS-CoV-2 and viral", "shape": "dot", "size": 21, "title": "\u003cb\u003einfected with SARS-CoV-2 and viral\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "neurocognitive and behavioral impairments", "label": "neurocognitive and behavioral impairments", "shape": "dot", "size": 24, "title": "\u003cb\u003eneurocognitive and behavioral impairments\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 3\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "neuroinflammation", "label": "neuroinflammation", "shape": "dot", "size": 30, "title": "\u003cb\u003eneuroinflammation\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 5\u003cbr\u003e\n    Incoming: 3\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "chronic disease", "label": "chronic disease", "shape": "dot", "size": 27, "title": "\u003cb\u003echronic disease\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 4\u003cbr\u003e\n    Incoming: 4\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "respiratory disease", "label": "respiratory disease", "shape": "dot", "size": 18, "title": "\u003cb\u003erespiratory disease\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681417"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "COVID-19 disease", "label": "COVID-19 disease", "shape": "dot", "size": 15, "title": "\u003cb\u003eCOVID-19 disease\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "anti-CD44", "label": "anti-CD44", "shape": "dot", "size": 21, "title": "\u003cb\u003eanti-CD44\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "pulmonary infection", "label": "pulmonary infection", "shape": "dot", "size": 18, "title": "\u003cb\u003epulmonary infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "mucormycosis", "label": "mucormycosis", "shape": "dot", "size": 24, "title": "\u003cb\u003emucormycosis\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 3\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 3\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "diabetes", "label": "diabetes", "shape": "dot", "size": 18, "title": "\u003cb\u003ediabetes\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "zinc", "label": "zinc", "shape": "dot", "size": 30, "title": "\u003cb\u003ezinc\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 5\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 4\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "Rhizopus arrhizus", "label": "Rhizopus arrhizus", "shape": "dot", "size": 24, "title": "\u003cb\u003eRhizopus arrhizus\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 3\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "hydrogen peroxide", "label": "hydrogen peroxide", "shape": "dot", "size": 21, "title": "\u003cb\u003ehydrogen peroxide\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "sodium chloride", "label": "sodium chloride", "shape": "dot", "size": 21, "title": "\u003cb\u003esodium chloride\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "amphotericin B", "label": "amphotericin B", "shape": "dot", "size": 18, "title": "\u003cb\u003eamphotericin B\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "posaconazole", "label": "posaconazole", "shape": "dot", "size": 18, "title": "\u003cb\u003eposaconazole\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "ergosterol", "label": "ergosterol", "shape": "dot", "size": 21, "title": "\u003cb\u003eergosterol\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "chitosan", "label": "chitosan", "shape": "dot", "size": 21, "title": "\u003cb\u003echitosan\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "iron", "label": "iron", "shape": "dot", "size": 27, "title": "\u003cb\u003eiron\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 4\u003cbr\u003e\n    Incoming: 4\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "Candida albicans", "label": "Candida albicans", "shape": "dot", "size": 15, "title": "\u003cb\u003eCandida albicans\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "fungal infection", "label": "fungal infection", "shape": "dot", "size": 15, "title": "\u003cb\u003efungal infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "coronavirus infection", "label": "coronavirus infection", "shape": "dot", "size": 18, "title": "\u003cb\u003ecoronavirus infection\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.680815"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "ATAC", "label": "ATAC", "shape": "dot", "size": 15, "title": "\u003cb\u003eATAC\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681330"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "Respiratory infectious diseases", "label": "Respiratory infectious diseases", "shape": "dot", "size": 15, "title": "\u003cb\u003eRespiratory infectious diseases\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681417"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "upper respiratory tract", "label": "upper respiratory tract", "shape": "dot", "size": 18, "title": "\u003cb\u003eupper respiratory tract\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681417"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "Ankara-(MVA)-SARS-2-ST", "label": "Ankara-(MVA)-SARS-2-ST", "shape": "dot", "size": 15, "title": "\u003cb\u003eAnkara-(MVA)-SARS-2-ST\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "140", "label": "140", "shape": "dot", "size": 15, "title": "\u003cb\u003e140\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "methacholine", "label": "methacholine", "shape": "dot", "size": 15, "title": "\u003cb\u003emethacholine\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "cough", "label": "cough", "shape": "dot", "size": 21, "title": "\u003cb\u003ecough\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "headache", "label": "headache", "shape": "dot", "size": 21, "title": "\u003cb\u003eheadache\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "fatigue", "label": "fatigue", "shape": "dot", "size": 21, "title": "\u003cb\u003efatigue\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 2\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "cancer", "label": "cancer", "shape": "dot", "size": 18, "title": "\u003cb\u003ecancer\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337497"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "HPV-associated cancer", "label": "HPV-associated cancer", "shape": "dot", "size": 18, "title": "\u003cb\u003eHPV-associated cancer\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337497"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "ResultsOverall", "label": "ResultsOverall", "shape": "dot", "size": 15, "title": "\u003cb\u003eResultsOverall\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337497"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "PD", "label": "PD", "shape": "dot", "size": 18, "title": "\u003cb\u003ePD\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337449"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "nirmatrelvir, and molnupiravir", "label": "nirmatrelvir, and molnupiravir", "shape": "dot", "size": 15, "title": "\u003cb\u003enirmatrelvir, and molnupiravir\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337449"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "toxicities", "label": "toxicities", "shape": "dot", "size": 15, "title": "\u003cb\u003etoxicities\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337449"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "PK", "label": "PK", "shape": "dot", "size": 18, "title": "\u003cb\u003ePK\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337449"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "Respiratory Syndrome", "label": "Respiratory Syndrome", "shape": "dot", "size": 21, "title": "\u003cb\u003eRespiratory Syndrome\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 2\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 2\u003cbr\u003e\n    DOI: 10.1101/2025.09.27.25336412"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "coronavirus disease 2019", "label": "coronavirus disease 2019", "shape": "dot", "size": 18, "title": "\u003cb\u003ecoronavirus disease 2019\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "label": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "shape": "dot", "size": 18, "title": "\u003cb\u003enirmatrelvir or remdesivir, suggesting the feasibility of treating\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "infections", "label": "infections", "shape": "dot", "size": 18, "title": "\u003cb\u003einfections\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "nirmatrelvir) and RdRp (remdesivir) inhibitors.", "label": "nirmatrelvir) and RdRp (remdesivir) inhibitors.", "shape": "dot", "size": 15, "title": "\u003cb\u003enirmatrelvir) and RdRp (remdesivir) inhibitors.\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "COVID-19 disease activity", "label": "COVID-19 disease activity", "shape": "dot", "size": 15, "title": "\u003cb\u003eCOVID-19 disease activity\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.05.25337392"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "LTLAs", "label": "LTLAs", "shape": "dot", "size": 15, "title": "\u003cb\u003eLTLAs\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.05.25337392"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "infectious diseases", "label": "infectious diseases", "shape": "dot", "size": 15, "title": "\u003cb\u003einfectious diseases\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.05.25337392"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "nontuberculous mycobacterial", "label": "nontuberculous mycobacterial", "shape": "dot", "size": 18, "title": "\u003cb\u003enontuberculous mycobacterial\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "NTM", "label": "NTM", "shape": "dot", "size": 27, "title": "\u003cb\u003eNTM\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 4\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 3\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "NTM-associated diseases", "label": "NTM-associated diseases", "shape": "dot", "size": 18, "title": "\u003cb\u003eNTM-associated diseases\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "Mycobacterium avium", "label": "Mycobacterium avium", "shape": "dot", "size": 18, "title": "\u003cb\u003eMycobacterium avium\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 1\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "avium", "label": "avium", "shape": "dot", "size": 18, "title": "\u003cb\u003eavium\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "terrae", "label": "terrae", "shape": "dot", "size": 18, "title": "\u003cb\u003eterrae\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "CoVs", "label": "CoVs", "shape": "dot", "size": 15, "title": "\u003cb\u003eCoVs\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.03.680419"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#3498db", "font": {"color": "black"}, "id": "nucleotide", "label": "nucleotide", "shape": "dot", "size": 15, "title": "\u003cb\u003enucleotide\u003c/b\u003e\u003cbr\u003e\n    Type: Drug\u003cbr\u003e\n    Total Connections: 0\u003cbr\u003e\n    Incoming: 0\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.10.03.680419"}, {"borderWidth": 2, "borderWidthSelected": 4, "color": "#e74c3c", "font": {"color": "black"}, "id": "SARS", "label": "SARS", "shape": "dot", "size": 18, "title": "\u003cb\u003eSARS\u003c/b\u003e\u003cbr\u003e\n    Type: Disease\u003cbr\u003e\n    Total Connections: 1\u003cbr\u003e\n    Incoming: 1\u003cbr\u003e\n    Outgoing: 0\u003cbr\u003e\n    DOI: 10.1101/2025.09.27.25336412"}]);
                  edges = new vis.DataSet([{"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.52\u003cbr\u003e\n    Context: Using an immortalized alveolar epithelial cell line, AXiAEC, and human lung microvascular endothelial cells (hLMVEC) we established a SARS-CoV-2 infection model on a LOC system.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "AXiAEC", "width": 2.5625}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.75\u003cbr\u003e\n    Context: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "ALI", "width": 3.2556390977443606}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.87\u003cbr\u003e\n    Context: Finally, we evaluated the application of the LOC SARS-CoV-2 infection model for efficacy testing and demonstrated the antiviral effect of remdesivir.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "LOC SARS-CoV-2 infection", "width": 3.608695652173913}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.94\u003cbr\u003e\n    Context: Tetramer staining of human PBMCs enriched CD4 T memory populations from healthy adult subjects highlighting this approach as a sensitive and specific method of identifying novel epitopes and subsequen\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682991", "to": "viral infections", "width": 3.830188679245283}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.48\u003cbr\u003e\n    Context: To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "infected with SARS-CoV-2 and viral", "width": 2.4285714285714284}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.69\u003cbr\u003e\n    Context: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dy\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "neurocognitive and behavioral impairments", "width": 3.083333333333333}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "infection", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.72\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "neuroinflammation", "width": 3.173913043478261}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "infection", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.75\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 3.2556390977443606}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "infection", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.51\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2.515151515151515}, {"arrowStrikethrough": false, "arrows": "to", "color": "#27ae60", "from": "infection", "label": "treated_by", "title": "\u003cb\u003eRelation: treated_by\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.42\u003cbr\u003e\n    Context: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces \u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000", "to": "anti-CD44", "width": 2.25}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.64\u003cbr\u003e\n    Context: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces \u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000", "to": "weight loss", "width": 2.9108280254777075}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.91\u003cbr\u003e\n    Context: Our findings demonstrate that disruption of HA-receptor interactions is a way to prevent inflammatory pathology in pulmonary infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000", "to": "pulmonary infection", "width": 3.7272727272727275}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.67\u003cbr\u003e\n    Context: However, vaccines against respiratory viruses predominantly have systemic administration routes that elicit strong responses in the circulation to prevent severe respiratory disease, but do not effect\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681417", "to": "respiratory disease", "width": 3.0}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "JN.1/KP.2", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.39\u003cbr\u003e\n    Context: We found that administration of the JN.1/KP.2 booster elicited broadly neutralizing antibody responses against recently circulating SARS-CoV-2 variants that were accounted for by recall of Wu S-induce\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682893", "to": "S-induced", "width": 2.171875}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "RBD", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.44\u003cbr\u003e\n    Context: Using a nanoluciferase (Nluc)-expressing attenuated recombinant SARS-CoV-2 lacking the open reading frames (ORF) 3a and 7b ({Delta}3a7b-Nluc), we characterized resistance profiles of two broadly prote\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699", "to": "{Delta}3a7b-Nluc", "width": 2.31578947368421}, {"arrowStrikethrough": false, "arrows": "to", "color": "#27ae60", "from": "RBD", "label": "treated_by", "title": "\u003cb\u003eRelation: treated_by\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.57\u003cbr\u003e\n    Context: In contrast, no ARM emerged under treatment with 1249A8, or an antibody cocktail of 1301B7 (RBD) + 1249A8 (SH).\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699", "to": "ARM", "width": 2.7045454545454546}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "{Delta}3a7b-Nluc", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.53\u003cbr\u003e\n    Context: Serial passaging of {Delta}3a7b-Nluc under selective pressure identified a 1301B7 antibody-resistant mutants (ARM-B7) harboring an RBD mutation (S371F) that conferred resistance to 1301B7 and other RB\u003cbr\u003e\n    DOI: 10.1101/2025.10.16.682699", "to": "ARM", "width": 2.5789473684210527}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "SARS-CoV-2 infection", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.70\u003cbr\u003e\n    Context: The most severe manifestation of COVID-19 is observed in the distal lung, where SARS-CoV-2 infection can result in massive inflammation and barrier breakdown.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "inflammation", "width": 3.0979020979020984}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "SARS-CoV-2 infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.90\u003cbr\u003e\n    Context: Therefore, we aimed to develop a Lung-on-Chip (LOC) model for studying SARS-CoV-2 infection at the alveolar barrier.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 3.7027027027027026}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "SARS-CoV-2 infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.55\u003cbr\u003e\n    Context: Using an immortalized alveolar epithelial cell line, AXiAEC, and human lung microvascular endothelial cells (hLMVEC) we established a SARS-CoV-2 infection model on a LOC system.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "AXiAEC", "width": 2.657458563535912}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "SARS-CoV-2 infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.82\u003cbr\u003e\n    Context: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "ALI", "width": 3.459016393442623}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "SARS-CoV-2 infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.96\u003cbr\u003e\n    Context: Finally, we evaluated the application of the LOC SARS-CoV-2 infection model for efficacy testing and demonstrated the antiviral effect of remdesivir.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "LOC SARS-CoV-2 infection", "width": 3.8846153846153846}, {"arrowStrikethrough": false, "arrows": "to", "color": "#27ae60", "from": "SARS-CoV-2 infection", "label": "treated_by", "title": "\u003cb\u003eRelation: treated_by\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.66\u003cbr\u003e\n    Context: Thus, AVI-6451 (4) is a potent Mac1 inhibitor lead with low intrinsic clearance, high oral bioavailability, and antiviral efficacy with once-daily oral administration in a mouse model of SARS-CoV-2 in\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833", "to": "once-daily", "width": 2.9867549668874176}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "inflammation", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.76\u003cbr\u003e\n    Context: The most severe manifestation of COVID-19 is observed in the distal lung, where SARS-CoV-2 infection can result in massive inflammation and barrier breakdown.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 3.2727272727272725}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "inflammation", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.43\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2.2987012987012987}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "viral infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.94\u003cbr\u003e\n    Context: Human-derived microphysiological systems pose a promising new class of in vitro models to study viral infection in a relevant context.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 3.830188679245283}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "AXiAEC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.68\u003cbr\u003e\n    Context: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683096", "to": "ALI", "width": 3.0408163265306123}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "trametinib", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.87\u003cbr\u003e\n    Context: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635", "to": "sorafenib", "width": 3.608695652173913}, {"arrowStrikethrough": false, "arrows": "to", "color": "#2ecc71", "from": "trametinib", "label": "treats", "title": "\u003cb\u003eRelation: treats\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.58\u003cbr\u003e\n    Context: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635", "to": "coronavirus infections", "width": 2.744186046511628}, {"arrowStrikethrough": false, "arrows": "to", "color": "#2ecc71", "from": "sorafenib", "label": "treats", "title": "\u003cb\u003eRelation: treats\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.64\u003cbr\u003e\n    Context: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\u003cbr\u003e\n    DOI: 10.1101/2025.10.15.682635", "to": "coronavirus infections", "width": 2.9108280254777075}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "Tyrosine", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.65\u003cbr\u003e\n    Context: Here, we performed a genome-wide CRISPRi screening to identify the host protein, Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate (HGS), as essential for the pan-coronaviruses infection bo\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077", "to": "pan-coronaviruses infection", "width": 2.948051948051948}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "riboflavin tetrabutyrate", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.79\u003cbr\u003e\n    Context: Leveraging this interaction, we designed M-derived peptides and screened over 5,000 FDA-approved drugs, identifying riboflavin tetrabutyrate (RTB).\u003cbr\u003e\n    DOI: 10.1101/2025.10.17.683077", "to": "RTB", "width": 3.380952380952381}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "nilotinib", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.47\u003cbr\u003e\n    Context: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938", "to": "tecovirimat", "width": 2.4150943396226414}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "nilotinib", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.42\u003cbr\u003e\n    Context: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938", "to": "ST-246", "width": 2.2658227848101262}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "tecovirimat", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.80\u003cbr\u003e\n    Context: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\u003cbr\u003e\n    DOI: 10.1101/2025.10.12.681938", "to": "ST-246", "width": 3.4000000000000004}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "urea", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.81\u003cbr\u003e\n    Context: Multiple strategies were pursued to overcome these issues, including replacing a urea function to reduce hydrogen bond donor count.\u003cbr\u003e\n    DOI: 10.1101/2025.10.11.681833", "to": "hydrogen bond donor", "width": 3.4193548387096775}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "uridine", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.70\u003cbr\u003e\n    Context: We examined different combinations of linear vectors: containing either N1-methylpseudouridines or uridine and capped with either ARCA (m7G(5\u0027)ppp(5\u0027)G) or CleanCap (m7G(5\u0027)ppp(5\u0027)m2G).\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682008", "to": "ARCA", "width": 3.0979020979020984}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PASC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.76\u003cbr\u003e\n    Context: While males are more likely to suffer severe outcomes during acute COVID-19, a greater proportion of females develop post-acute sequalae of COVID-19 (PASC) despite similar rates of infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "infection", "width": 3.2900763358778624}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PASC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.86\u003cbr\u003e\n    Context: To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "infected with SARS-CoV-2 and viral", "width": 3.586206896551724}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PASC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.69\u003cbr\u003e\n    Context: Sex differences in inflammation and cognitive phenotypes during PASC were mediated by the presence of two X chromosomes.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 3.0689655172413794}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PASC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.82\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "neuroinflammation", "width": 3.459016393442623}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PASC", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.47\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2.4018691588785046}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "neurocognitive and behavioral impairments", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.48\u003cbr\u003e\n    Context: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dy\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "neuroinflammation", "width": 2.44927536231884}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "neurocognitive and behavioral impairments", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.47\u003cbr\u003e\n    Context: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dy\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 2.4150943396226414}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "neuroinflammation", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.95\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 3.857142857142857}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "neuroinflammation", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.42\u003cbr\u003e\n    Context: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic di\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2.271186440677966}, {"arrowStrikethrough": false, "arrows": "to", "color": "#2ecc71", "from": "anti-CD44", "label": "treats", "title": "\u003cb\u003eRelation: treats\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.55\u003cbr\u003e\n    Context: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces \u003cbr\u003e\n    DOI: 10.1101/2025.10.13.682000", "to": "weight loss", "width": 2.639344262295082}, {"arrowStrikethrough": false, "arrows": "to", "color": "#e67e22", "from": "mucormycosis", "label": "causes", "title": "\u003cb\u003eRelation: causes\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.52\u003cbr\u003e\n    Context: During COVID-19 pandemic, the cases of mucormycosis increased substantially, with rhino-orbito-cerebral form linked to uncontrolled diabetes being the predominant manifestation.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "diabetes", "width": 2.55440414507772}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "mucormycosis", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.62\u003cbr\u003e\n    Context: Some clinical and epidemiological studies associated the usage of zinc supplements with the occurrence of COVID-19 associated mucormycosis, but experimental evidence remains limited.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "zinc", "width": 2.875}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "mucormycosis", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.65\u003cbr\u003e\n    Context: This study aimed to elucidate the impact of zinc enrichment on Rhizopus arrhizus, the predominant causative agent of mucormycosis.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "Rhizopus arrhizus", "width": 2.948051948051948}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "zinc", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.84\u003cbr\u003e\n    Context: This study aimed to elucidate the impact of zinc enrichment on Rhizopus arrhizus, the predominant causative agent of mucormycosis.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "Rhizopus arrhizus", "width": 3.5210084033613445}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "zinc", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.37\u003cbr\u003e\n    Context: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen pero\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "hydrogen peroxide", "width": 2.0989010989010985}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "zinc", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.33\u003cbr\u003e\n    Context: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen pero\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "sodium chloride", "width": 1.9836065573770494}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "zinc", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.38\u003cbr\u003e\n    Context: The work demonstrates that zinc supplementation supports Rhizopus arrhizus growth, metabolism and stress response, and enhances the expression of key virulence factors, including mucoricin and iron tr\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2.1278195488721803}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "Rhizopus arrhizus", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.42\u003cbr\u003e\n    Context: The work demonstrates that zinc supplementation supports Rhizopus arrhizus growth, metabolism and stress response, and enhances the expression of key virulence factors, including mucoricin and iron tr\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2.271186440677966}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "hydrogen peroxide", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.76\u003cbr\u003e\n    Context: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen pero\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "sodium chloride", "width": 3.2727272727272725}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "amphotericin B", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.84\u003cbr\u003e\n    Context: Susceptibility to amphotericin B and posaconazole was unchanged.\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "posaconazole", "width": 3.5210084033613445}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "ergosterol", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.80\u003cbr\u003e\n    Context: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, m\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "chitosan", "width": 3.4000000000000004}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "ergosterol", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.51\u003cbr\u003e\n    Context: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, m\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2.515151515151515}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "chitosan", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.58\u003cbr\u003e\n    Context: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, m\u003cbr\u003e\n    DOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2.734104046242775}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "coronavirus infection", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.89\u003cbr\u003e\n    Context: Here, we report that coronavirus infection causes cytoplasmic poly(A)-binding protein (PABPC) activity to become limiting, which preferentially destabilizes short-tailed host mRNAs, occurring before t\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.680815", "to": "infection", "width": 3.6785714285714284}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "upper respiratory tract", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.48\u003cbr\u003e\n    Context: The upper respiratory tract (URT) represents the primary access point for respiratory viruses, where initial host infection occurs.\u003cbr\u003e\n    DOI: 10.1101/2025.10.09.681417", "to": "infection", "width": 2.4285714285714284}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "cough", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.93\u003cbr\u003e\n    Context: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492", "to": "headache", "width": 3.803738317757009}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "cough", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.83\u003cbr\u003e\n    Context: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492", "to": "fatigue", "width": 3.479338842975207}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "headache", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.88\u003cbr\u003e\n    Context: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337492", "to": "fatigue", "width": 3.631578947368421}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "cancer", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.87\u003cbr\u003e\n    Context: Focusing on Iowa, a state with the fastest rising incidence of HPV-associated cancer, we evaluated if county-level COVID-19 vaccination rates corresponded to county-level changes in rural-urban HPV va\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337497", "to": "HPV-associated cancer", "width": 3.608695652173913}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "PD", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.79\u003cbr\u003e\n    Context: Participants were monitored for 43 weeks to evaluate safety, pharmacokinetics (PK), and pharmacodynamics (PD; serum live virus neutralization).\u003cbr\u003e\n    DOI: 10.1101/2025.10.07.25337449", "to": "PK", "width": 3.3622047244094486}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "Respiratory Syndrome", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.53\u003cbr\u003e\n    Context: Ensitrelvir is an antiviral drug that specifically targets the main protease (Mpro) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been approved for the treatment of coronavirus d\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586", "to": "coronavirus disease 2019", "width": 2.60427807486631}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "Respiratory Syndrome", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.74\u003cbr\u003e\n    Context: BackgroundThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has continued to be a global health threat despite many interventions put with new variants noticed.\u003cbr\u003e\n    DOI: 10.1101/2025.09.27.25336412", "to": "SARS", "width": 3.2058823529411766}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.60\u003cbr\u003e\n    Context: Positively, G23del in Mpro does not render SARS-CoV-2 resistant to nirmatrelvir or remdesivir, suggesting the feasibility of treating infections with SARS-CoV-2 containing G23del with these other appr\u003cbr\u003e\n    DOI: 10.1101/2025.09.30.679586", "to": "infections", "width": 2.796407185628743}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "nontuberculous mycobacterial", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.77\u003cbr\u003e\n    Context: BackgroundThe incidence of nontuberculous mycobacterial (NTM) diseases is increasing globally, with risk factors remaining poorly understood.\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223", "to": "NTM", "width": 3.3076923076923075}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "NTM", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.83\u003cbr\u003e\n    Context: COVID-19 may alter respiratory tract conditions affecting NTM colonization and infection patterns.\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223", "to": "infection", "width": 3.479338842975207}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "NTM", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.76\u003cbr\u003e\n    Context: ObjectiveTo evaluate species diversity of NTM isolated from patients with NTM-associated diseases with and without a history of COVID-19.\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223", "to": "NTM-associated diseases", "width": 3.2727272727272725}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "NTM", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.48\u003cbr\u003e\n    Context: Conversely, rare NTM species showed increased prevalence in COVID-19+ patients: M. kansasii complex (0% vs 8.1%, p\u003c0.05), M. terrae complex (0% vs 3.3%, p\u003c0.05), M. simiae complex (0.5% vs 7.0%, p\u003c0.0\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223", "to": "terrae", "width": 2.442307692307692}, {"arrowStrikethrough": false, "arrows": "to", "color": "#95a5a6", "from": "Mycobacterium avium", "label": "associated_with", "title": "\u003cb\u003eRelation: associated_with\u003c/b\u003e\u003cbr\u003e\n    Confidence: 0.88\u003cbr\u003e\n    Context: COVID-19 was associated with a significant 28% reduction in Mycobacterium avium complex (MAC) prevalence (94.8% vs 66.8%, p\u003c0.05), primarily due to decreased M. avium isolation (80.3% vs 52.0%, p\u003c0.05\u003cbr\u003e\n    DOI: 10.1101/2025.10.02.25337223", "to": "avium", "width": 3.631578947368421}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": true,
        "filter": [
            "physics"
        ]
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "barnesHut": {
            "avoidOverlap": 0,
            "centralGravity": 0.3,
            "damping": 0.09,
            "gravitationalConstant": -8000,
            "springConstant": 0.001,
            "springLength": 200
        },
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  
                  // if this network requires displaying the configure window,
                  // put it in its div
                  options.configure["container"] = document.getElementById("config");
                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>